S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 2.29 USD 1.33%
Market Cap: 193.9m USD
Have any thoughts about
Stereotaxis Inc?
Write Note

Stereotaxis Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stereotaxis Inc
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
S
Stereotaxis Inc
AMEX:STXS
Accounts Payable
$6.4m
CAGR 3-Years
18%
CAGR 5-Years
44%
CAGR 10-Years
10%
Becton Dickinson and Co
NYSE:BDX
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accounts Payable
$907m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Accounts Payable
$1.3B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
15%
Abbott Laboratories
NYSE:ABT
Accounts Payable
$4.1B
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
16%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Payable
$218.7m
CAGR 3-Years
22%
CAGR 5-Years
11%
CAGR 10-Years
15%
No Stocks Found

Stereotaxis Inc
Glance View

Market Cap
194m USD
Industry
Health Care

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.

STXS Intrinsic Value
1.41 USD
Overvaluation 39%
Intrinsic Value
Price
S

See Also

What is Stereotaxis Inc's Accounts Payable?
Accounts Payable
6.4m USD

Based on the financial report for Sep 30, 2024, Stereotaxis Inc's Accounts Payable amounts to 6.4m USD.

What is Stereotaxis Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
10%

Over the last year, the Accounts Payable growth was 98%. The average annual Accounts Payable growth rates for Stereotaxis Inc have been 18% over the past three years , 44% over the past five years , and 10% over the past ten years .

Back to Top